Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

U.S. And Korea Step Up Fight Against Tuberculosis, Launch TB Research Center

This article was originally published in PharmAsia News

Executive Summary

SEOUL - In a bid to wipe out perceptions that South Korea remains a "safe heaven" for tuberculosis, the country is strengthening cooperation with the U.S. in a joint attack on the potentially fatal disease

You may also be interested in...



South Korea Gearing Up To Fight Tuberculosis

To eliminate perceptions that South Korea stands out among OECD countries as a safe haven for TB, the government is rolling out specific tools to combat the deadly lung disease.

Korea And U.S. Health Ministers Agree To Enhance Cooperation In Anticipation Of Increased Pharma, Device Trade

SEOUL - South Korea and the U.S. have agreed to strengthen their relationship in the healthcare sector through personnel and information exchanges on food and drug regulations, but an official at South Korea's Ministry of Health and Welfare denied Korean media reports that the countries formalized the agreement with a memorandum of understanding

Korea And U.S. Health Ministers Agree To Enhance Cooperation In Anticipation Of Increased Pharma, Device Trade

SEOUL - South Korea and the U.S. have agreed to strengthen their relationship in the healthcare sector through personnel and information exchanges on food and drug regulations, but an official at South Korea's Ministry of Health and Welfare denied Korean media reports that the countries formalized the agreement with a memorandum of understanding

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071120

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel